Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what representations (a) he and (b) his officials are making to counterparts in Malta on allowing British travellers arriving in Malta who have received the AstraZeneca/Oxford covid-19 vaccines sourced from the Serum Institute of India to follow regulations in Malta in-line with people who are fully vaccinated with other approved covid-19 vaccines.

The Government is in close touch with partners across Europe, including Malta, on the issue of the 5 million doses of AstraZeneca that were manufactured by the Serum Institute of India for use in the UK, called Vaxzevria. The European Medicines Agency, as well as our own medicines regulator, has authorised this vaccine and travel should not be affected. We have confirmed with the Maltese authorities that all vaccines delivered in the UK, regardless of type, batch or location of manufacture, are sufficient for entry into Malta.